Hester Biosciences Limited (BOM:524669)
India · Delayed Price · Currency is INR 2,351.55
-68.00 (-2.81%)
At close: Nov 6, 2026
Hester Biosciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 272.37 | 30.73 | 59.65 | 127.48 | 131.56 | 247.5 |
Short-Term Investments | - | 34.65 | 12.54 | 25.56 | 16.61 | 4.53 |
Cash & Short-Term Investments | 272.37 | 65.38 | 72.19 | 153.04 | 148.17 | 252.03 |
Cash Growth | 243.12% | -9.43% | -52.83% | 3.29% | -41.21% | 18.50% |
Accounts Receivable | 816.94 | 953.56 | 731.81 | 786.45 | 796.31 | 552.8 |
Other Receivables | - | 84.78 | 69.08 | 57.85 | 59.97 | 17.63 |
Receivables | 819.84 | 1,039 | 858.45 | 902.86 | 916.18 | 631.23 |
Inventory | 788.5 | 725.33 | 703.77 | 755.81 | 848.1 | 753.82 |
Prepaid Expenses | - | 11.01 | 16.8 | 12.72 | 12.83 | 23.9 |
Other Current Assets | 337.27 | 244.49 | 300.53 | 321.72 | 350.64 | 286.65 |
Total Current Assets | 2,218 | 2,086 | 1,952 | 2,146 | 2,276 | 1,948 |
Property, Plant & Equipment | 3,973 | 4,111 | 4,094 | 4,076 | 4,050 | 3,170 |
Long-Term Investments | 444.93 | 429.69 | 356.65 | 306.64 | 267.31 | 241 |
Other Intangible Assets | 112.79 | 97.22 | 66.57 | 39.32 | 29.36 | 20.44 |
Other Long-Term Assets | 83.91 | 56.26 | 65.36 | 55.53 | 76.68 | 242.17 |
Total Assets | 6,833 | 6,779 | 6,534 | 6,623 | 6,700 | 5,622 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 228.72 | 246.8 | 294.19 | 258.56 | 299.77 | 180.18 |
Accrued Expenses | - | 168.78 | 90.45 | 21.37 | 29.65 | 16.27 |
Short-Term Debt | - | 242.86 | 295.79 | 313.51 | 588.58 | 348.45 |
Current Portion of Long-Term Debt | 587.74 | 740.05 | 448.28 | 389.24 | 243.17 | 230.65 |
Current Portion of Leases | 2.25 | 2.28 | - | 0.42 | 5 | 4.44 |
Current Income Taxes Payable | 21.42 | 50.02 | 40.17 | 24.56 | 33.95 | 9.38 |
Current Unearned Revenue | - | 39.18 | 5.04 | 5.04 | 12.73 | - |
Other Current Liabilities | 148.87 | 34.81 | 77.92 | 42.02 | 274.11 | 179.6 |
Total Current Liabilities | 989 | 1,525 | 1,252 | 1,055 | 1,487 | 968.97 |
Long-Term Debt | 433.54 | 899.64 | 1,334 | 1,820 | 1,848 | 1,644 |
Long-Term Leases | 61.65 | 63.11 | 54.75 | 53.78 | 56.69 | 54.4 |
Long-Term Unearned Revenue | - | 502.55 | 540.16 | 543.81 | 329.64 | 202.74 |
Pension & Post-Retirement Benefits | - | - | 3.74 | 2.64 | 2.16 | 2.34 |
Long-Term Deferred Tax Liabilities | 92.07 | 88.08 | 59.33 | 74.11 | 73.51 | 65.1 |
Other Long-Term Liabilities | 502.86 | 23.36 | 23.79 | 45.22 | 17.16 | 10.38 |
Total Liabilities | 2,079 | 3,102 | 3,267 | 3,595 | 3,814 | 2,948 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 85.07 | 85.07 | 85.07 | 85.07 | 85.07 | 85.07 |
Additional Paid-In Capital | - | 175.07 | 175.07 | 175.07 | 175.07 | 175.07 |
Retained Earnings | - | 3,260 | 2,763 | 2,543 | 2,423 | 2,240 |
Comprehensive Income & Other | 4,593 | 82.67 | 119.29 | 114.64 | 114.48 | 99.33 |
Total Common Equity | 4,678 | 3,602 | 3,143 | 2,918 | 2,797 | 2,600 |
Minority Interest | 75.72 | 75.54 | 124.01 | 110.82 | 88.16 | 74.09 |
Shareholders' Equity | 4,753 | 3,678 | 3,267 | 3,029 | 2,885 | 2,674 |
Total Liabilities & Equity | 6,833 | 6,779 | 6,534 | 6,623 | 6,700 | 5,622 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 1,085 | 1,948 | 2,133 | 2,577 | 2,742 | 2,282 |
Net Cash (Debt) | -812.81 | -1,883 | -2,060 | -2,424 | -2,593 | -2,030 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -94.45 | -221.30 | -242.19 | -284.99 | -304.85 | -238.59 |
Filing Date Shares Outstanding | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Total Common Shares Outstanding | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 |
Working Capital | 1,229 | 560.84 | 699.9 | 1,091 | 788.96 | 978.66 |
Book Value Per Share | 549.92 | 423.46 | 369.41 | 343.01 | 328.83 | 305.62 |
Tangible Book Value | 4,565 | 3,505 | 3,076 | 2,879 | 2,768 | 2,579 |
Tangible Book Value Per Share | 536.66 | 412.04 | 361.59 | 338.39 | 325.38 | 303.22 |
Land | - | 83.54 | 136.36 | 136.36 | 136.36 | 102.62 |
Buildings | - | 1,987 | 1,552 | 1,554 | 1,594 | 1,396 |
Machinery | - | 3,704 | 2,141 | 2,053 | 2,059 | 1,921 |
Construction In Progress | - | - | 1,767 | 1,681 | 1,461 | 802.24 |